Papp shared insights from the recent STRIDE phase 2 trial, which met all its primary and secondary endpoints. Data was presented at the American Academy of Dermatology Annual Meeting.
Kim Papp, MD, PhD, FRCPC
Advertisement
Articles by Kim Papp, MD, PhD, FRCPC
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Dermatology Times
1
How Emerging Androgenetic Alopecia Therapies Target DHT at the Scalp Level
2
Tildrakizumab Partially Reverses Epigenetic Aging in Psoriasis, Pilot Study Shows
3
Field-Directed Therapy Favored for Actinic Keratosis Management
4
Diet Linked to Improved Chronic Idiopathic Urticaria Control
5